{"name":"Granular Therapeutics Limited","slug":"granular-therapeutics-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9SN3BsNHRWTE1QS3k0aktta1hEMHBtVUxWZjlOT1VoNVFDQWFLc2hoa0ZUc0swM3NiSzc4aVV3azkxMGZHMlNjV2ttZVVRQS1md2ZuWDdKci1xMGVkejhyUlo3bTMwb0l0bHhLVE9pZ1I4VmRNMlVHa2k3TQ?oc=5","date":"2026-03-17","type":"pipeline","source":"ScienceDirect.com","summary":"Fundamental assembly to performance cues of granular hydrogel based therapeutics for advanced biomedical applications - ScienceDirect.com","headline":"Fundamental assembly to performance cues of granular hydrogel based therapeutics for advanced biomedical applications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPbjVpeDVjd1VnUXVfN3lLOExzV01QT1MxYmhnTVg1OHZDWFIwRGVMalJBcnNvWlFTTEdkc20yTFN4MkFxbnQtQ2JxNmlHOE90MVRpNkY5TG9FMGh4UWN6NzI4T0JXdEVHLWg2MzdKamtIZU02TjVOenYzbk9pLTVYZGNHLU9leFdFa2hEbVZoaUtYMGVBSHYzT1NXLXFFVmVHTXlibWs3THZZSEJqdEs4TlN3VVllRWlDRG1zcUtLYTJoRTc5WEdjVWgybw?oc=5","date":"2025-06-12","type":"trial","source":"Dermatology Times","summary":"Alys Pharmaceuticals Submits ALY-301 Clinical Trial Application in Germany for Cold Urticaria - Dermatology Times","headline":"Alys Pharmaceuticals Submits ALY-301 Clinical Trial Application in Germany for Cold Urticaria","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-02-21","type":"deal","source":"The Economic Times","summary":"Granules acquires Swiss firm for Rs 192 cr; forays into CDMO space - The Economic Times","headline":"Granules acquires Swiss firm for Rs 192 cr; forays into CDMO space","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPQXM2TzRGdVo4MWQ1RjMxNENFM1VZam1GNEtONTVGMmN1bFpGaFFJUElqc0doQTNPRnVsMmpXd0ZPTGJZUURBQWt3NWk4OWJUYUpDVDBmc2VWTFlrbEVWZGZHSkVPSlZmdXpValdTdWVDVDFUemVtcFZWT1F5blJBaENWa3BMUUtzcThUOW9nOUNpSWk1UWtfcktGSVRqVUxOeUp0S2xCM3o0dlFwOVJXUWJSYVM?oc=5","date":"2024-02-19","type":"pipeline","source":"PMLiVE","summary":"Medicxi forms Alys Pharma with six dermatology-focused companies with $100m - PMLiVE","headline":"Medicxi forms Alys Pharma with six dermatology-focused companies with $100m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOWHlRYV90N2txWkNnb21kc3ZUZVZUTFJxSVI0UUcwdnZoVlk0ZWNZN2hjYzZhRGtFeTRnWEtGOFFtUUhreEZfMXFuajIxWENHelhNckFYeWhCaG1kZEJYdEg2YlVXMU5aLWthRVF6ZG91OXM5emJMQng1X09sbU1KZ1k2Uk16cmZlZm1rejhwOTJ1aUlnb2hmMVlB?oc=5","date":"2024-02-19","type":"pipeline","source":"Greater Geneva Bern area","summary":"Alys Pharmaceuticals launches in Geneva with USD 100 million investment - Greater Geneva Bern area","headline":"Alys Pharmaceuticals launches in Geneva with USD 100 million investment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQM1BRV1ZmY0wwbTZNTUd6MzE1S2FRdmI5SXpXRGN2aXJ2ZnVFQVh4MS1oSlJERTJqS3dfQ3UtenBXbkFvM2pwWlptTXNEWk1IS1BpeTB5NlFFZ2RXYnVfcDdFSVN1NVdKOHk5Qll6YWNndElJSEtmaVRSV245ZWJ2MmtER3hBYnZEMHFXR3RUemk?oc=5","date":"2022-09-08","type":"pipeline","source":"Fortune Business Insights","summary":"India Womens Health Therapeutics Market Size | Report [2029] - Fortune Business Insights","headline":"India Womens Health Therapeutics Market Size | Report [2029]","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxNZkF4UGxkclhXblNxUnRjSmotWEpzbFlfWERFblZyMk5qSWE0bTFZUFJTUGpRT1N3ODVmZmZNVkk4YmpHTXVMWDFzOXZKeUhmUU9TMnh4MFRKQlhldlZkTVEwVE40S2pNSUlCemtHaFUzVDRhY0s5d1d4VTJhamdQU1d0NTdremxKeXk0ajBVSF85ZmNkMXZFUXdXYms0ZVlJMU9rWUhsYnFXWDNHeUh6NWszeFIyeEw1dVM2MmRQNHBLV2I0Z29kZ0lXYzdUVk9zQmNPeEU1REtQMG1zYmtJOGFybklRczZublNhRjhHbWVXVUJRMVNPVGtERXN1bU9PRndRbTBWSHptN3BBcVJvX0dKbEtDVEpTVlMwT2ZB?oc=5","date":"2021-12-07","type":"regulatory","source":"PR Newswire","summary":"Saol Therapeutics Announces FDA Approval of LYVISPAH™ (baclofen) Oral Granules and the Divesture of its Plasma-derived Hyperimmune Portfolio - PR Newswire","headline":"Saol Therapeutics Announces FDA Approval of LYVISPAH™ (baclofen) Oral Granules and the Divesture of its Plasma-derived H","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9Ua1NrVmxDR2pQSXBoQXRGUmZpelFDT3ZocTZuYXg5LVpWc0FEOUpTeEkwVGlEdXV5dmJzVldnSVVFeXNTTUVtMkphX2ctZ1ZUbWI5T01wSnVSbXlsd3dwcQ?oc=5","date":"2020-12-01","type":"regulatory","source":"Straits Research","summary":"Aspartame Market Size, Share, Growth, Demand & Forecast 2033 - Straits Research","headline":"Aspartame Market Size, Share, Growth, Demand & Forecast 2033","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}